Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05745389 · ClinicalTrials.gov registry record
CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
A clinical trial of Alopecia Areata, sponsored by CorEvitas.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT05745389: Recruiting study of Alopecia Areata, sponsored by CorEvitas.
NCT05745389 is a study of Alopecia Areata that is actively recruiting participants, run by CorEvitas. The registered enrollment target is 5,000 participants, above the 1,763-participant average among 26 other Alopecia Areata trials with a reported enrollment target (184% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05745389, a study of Alopecia Areata, is actively recruiting participants, sponsored by CorEvitas.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
Primary Outcome
The major clinical outcomes include an assessment of the epidemiology of AA; to better understand the presentation, natural history, management and outcomes.
Conditions Studied
Study Locations (1)
Massachusetts
- CorEvitas, LLC - Waltham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2022-10-25 |
| Est. Completion | 2099-12-31 |
What NCT05745389 shows while recruiting
NCT05745389 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,763-participant average among 26 other Alopecia Areata trials with a reported enrollment target (184% higher).
The record links to 1 condition, with Alopecia Areata appearing as the primary indexed condition, and to 0 interventions.
NCT05745389 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05745389 about?
NCT05745389 is a clinical study titled "CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry". Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
What is the current status of trial NCT05745389?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2022-10-25. Estimated completion is 2099-12-31.
What conditions does trial NCT05745389 study?
This clinical trial studies the following conditions: Alopecia Areata.
Who is sponsoring clinical trial NCT05745389?
This trial is sponsored by CorEvitas, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05745389 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alopecia Areata
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05745389's enrollment target sits among peer trials
5,000 3rd of 26 higher than 24 of 26 other Alopecia Areata trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alopecia Areata trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
RECRUITING · Phase 2
-
A Study of LAD603 in Adults With Alopecia Areata
RECRUITING · Phase 2
-
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
RECRUITING · Phase 1
-
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
RECRUITING
-
Dupilumab in the Treatment of Pediatric Alopecia Areata
RECRUITING · Phase 2
-
Intralesional Cyclosporine for Alopecia Areata
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI